The National Institutes of Health, USA has released recommendations that provide a framework for a bold and transformative Alzheimer’s disease research agenda.

Developed at the February 2015 Alzheimer’s Disease Research Summit 2015: Path to Treatment and Prevention, the highly anticipated recommendations provide the wider Alzheimer’s research community with a strategy for speeding the development of effective interventions for Alzheimer’s and related dementias.

These recommendations call for a change in how the academic, biopharmaceutical and government sectors participating in Alzheimer’s research and therapy generate, share and use knowledge to propel the development of critically needed therapies.

Links

Link to NIH website news

4 Μαΐου, 2015